|Articles|November 15, 2016
SCRS Welcomes GlaxoSmithKline as a Global Impact Partner
The Society for Clinical Research Sites (SCRS) has announced GlaxoSmithKline (GSK) as its newest Global Impact Partner (GIP).
Advertisement
The Society for Clinical Research Sites (SCRS) has announced GlaxoSmithKline (GSK) as its newest Global Impact Partner (GIP). As a GIP, GSK will serve on the SCRS Global Impact Board and work closely with the organization’s Leadership Council on setting and working toward strategic initiatives.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
From Participation to Understanding: Reframing Engagement in Clinical Trials
2
Recruitment in the Age of AI: Q&A with John Worden, Javara
3
Lab Orchestration Is Not What You Think It Is
4
Why Seizure Counts Alone Can't Define Success in Epilepsy Trials
5